Clinical Trials
49 trialsESME OC
UNICANCER
Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies
National Institutes of Health Clinical Center (CC)
SCOUT-1
AstraZeneca
BIOC
KU Leuven
DESCENT-1
A2 Biotherapeutics Inc.
Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
National Institutes of Health Clinical Center (CC)
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
Stanford University
Prospective Sample Collection Study for a Blood-Based cfDNA Methylation Assay for Ovarian Cancer Detection
Tongji Hospital
RESO
Zhejiang Cancer Hospital
MONITOR-UK
Royal Marsden NHS Foundation Trust
National Cancer Institute "Cancer Moonshot Biobank"
National Cancer Institute (NCI)
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
National Institutes of Health Clinical Center (CC)
LONGEVITI
University of Alberta
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
National Institutes of Health Clinical Center (CC)
iCaRe2
University of Nebraska
Cognitive Impact of Neoadjuvant Chemotherapy for Ovarian Cancer
University of Wisconsin, Madison
retroESGO ov1
European Society of Gynaecological Oncology
REFLECT
University Health Network, Toronto
DP-04
AstraZeneca
BASECAMP-1
A2 Biotherapeutics Inc.
OLIVIA
AstraZeneca
GYNECO-IMM&CO
Centre Leon Berard
PROBE-II
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
CER
Cancer Support Community, Research and Training Institute, Philadelphia
DARE-part1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Diagnostic Utility of Culdocentesis in Patients With a Suspicious Adnexal Mass
Southern Illinois University
ConFeR
AbbVie
EPOCA
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
ECHO
Mayo Clinic
Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study
University of Washington
Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer
M.D. Anderson Cancer Center
Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer
M.D. Anderson Cancer Center
A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer
Peking University Third Hospital
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
National Institutes of Health Clinical Center (CC)
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer
SWOG Cancer Research Network
A Study of Niraparib in Patients With Ovarian Cancer in Clinical Practice
Takeda
TraveraRTGx
Travera Inc
The Registry of Genetic Alterations of Taiwan Ovarian Cancer
National Health Research Institutes, Taiwan
SENTRY
University of Utah
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
Multidimensional Burden of Platinum Resistant Ovarian Cancer (PROC) on Patients and Caregivers in Canada
PeriPharm
OVAmiARN
ZIWIG
Estrogen, Diet, Genetics and Endometrial Cancer
Memorial Sloan Kettering Cancer Center
ASAP
Avera McKennan Hospital & University Health Center
(CLOCS-2)
Imperial College London
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Wake Forest University Health Sciences
PRO-ACTIVE
Fondazione del Piemonte per l'Oncologia
EORTC QOL-OV39
Helios University Hospital Wuppertal
PROVE
Catholic University of the Sacred Heart